Pareen Vora

See our new publication on the importance of Understanding Causes of Death in Patients With ARDS journals.lww.com/ccejournal/ful…

Great to see the impact of our work on Pulmonary thromboembolic events in COVID-19 which was published in Pulmonary Circulation is now one of their top 10 most-cited papers for 2022-23! doi.org/10.1002/pul2.1…

Characteristics of adults with potential refractory chronic cough identified using an algorithm designed for administrative claims databases: A descriptive study journals.sagepub.com/doi/10.1177/00…

Congratulations @pareenvora , all my Indian friends and all the Humanity!

See our new publication of study design of a prospective study on persistence and adherence. sciencedirect.com/science/articl…

See our recent publication summarizing the global epidemiology of gastrointestinal bleeding in general population wjgnet.com/1948-9366/full…

Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study - bit.ly/3rwv9PH

Read our publication on CardioAspirin and Gastrointestinal Cancer prevention in Hong Kong bmjopen.bmj.com/content/12/2/e…

Read our publication on Oral Anticoagulants utilization trends in 5 countries and 9 data sources using #TreatmentPathway tool and #ATLAS #OHDSI #OMOP #CDM #LargeScaleAnalytics #DataVisualization hindawi.com/journals/ijclp… via @Hindawi

Gender Stereotypes | Zoe Cash | TEDxYouth@BerlinCosmopolitanSchool youtu.be/SCwqQcExWqY via @YouTube

Read our publication on the public health impact of low-dose aspirin! sciencedirect.com/science/articl…

Read more about our study published as open access in The Patient - Patient Centered Outcomes Research. link.springer.com/article/10.100…

Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network onlinelibrary.wiley.com/doi/10.1002/pd…

Thirty-Year Incidence and Mortality Trends in Gastrointestinal Bleeding in Finland ja.ma/3iXYxXG via @JAMANetworkOpen part of @JAMANetwork

1/ We don't have a vaccine yet, but we have a treatment that may reduce the risk of #COVID19 by 20% without serious side effects. That treatment is #hydroxychloroquine. Risk ratio of COVID-19 in our meta-analysis of 3 prophylaxis randomized trials: 0.78 medrxiv.org/content/10.110…

4/ Update #1 The findings from a fourth randomized trial were published today. They change neither the risk ratio estimate nor our conclusion: We need additional randomized trials to obtain a more precise estimate of the effect of #hydroxychloroquine, overall and in subgroups.

#Clinicaltrials rebound after COVID-19 crash, but can enrollment gains continue? sciencemag.org/news/2020/07/c… @pareenvora @SuzartK @alexhabs @mrpusch

@yeysus @SuzartK @FariqRed @Bayer @YoSoyMayonesa @jotka @KYepitsme @alexhabs @MaikelMoheb @JulesHitz @mrpusch @VanessaLemarie Can you send me the link? I would like to try as well.

@SuzartK @pareenvora @FariqRed @Bayer @YoSoyMayonesa @jotka @KYepitsme @alexhabs @MaikelMoheb @JulesHitz @mrpusch @VanessaLemarie Exactly. I would have had it behind me, assuming those IgGs are neutralizing.

My #coronavirus #COVID19 test finally arrived 3 MONTHS after I ordered it. I hope it works. 10 tests are in. Will show results to my friends at the #MITCOVID18CHALLENGE , @FariqRed , and @Bayer .

@yeysus @FariqRed @Bayer @YoSoyMayonesa @jotka @SuzartK @KYepitsme @alexhabs @MaikelMoheb @JulesHitz @mrpusch @VanessaLemarie Why a sad smiley? 😬

@pareenvora @FariqRed @Bayer @YoSoyMayonesa @jotka @SuzartK @KYepitsme @alexhabs @MaikelMoheb @JulesHitz @mrpusch @VanessaLemarie Negative me and my wife :-((((